enow.com Web Search

  1. Ad

    related to: neuromyelitis optica spectrum disorder prognosis treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Neuromyelitis optica spectrum disorder - Wikipedia

    en.wikipedia.org/wiki/Neuromyelitis_optica...

    A retrospective study found that prevalence of neuromyelitis optica spectrum disorders was 1.5% among a random sample of neurological patients, with a MS:NMOSD ratio of 42:7. Among 13 NMOSD patients, 77% had long spinal cord lesions, 38% had severe optic neuritis, and 23% had brain or brainstem lesions. Only 56% had clinically definite NMO at ...

  3. Anti-AQP4 disease - Wikipedia

    en.wikipedia.org/wiki/Anti-AQP4_disease

    Anti-AQP4 diseases, are a group of diseases characterized by auto-antibodies against aquaporin 4.. After the discovery of anti-AQP4 autoantibody in neuromyelitis optica, it was found that it was also present in some patients with other clinically defined diseases, including multiple sclerosis variants like optic-spinal MS.

  4. Inebilizumab - Wikipedia

    en.wikipedia.org/wiki/Inebilizumab

    Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults. [8] [9] [5] Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells.

  5. MOG antibody disease - Wikipedia

    en.wikipedia.org/wiki/MOG_antibody_disease

    Anti-MOG antibodies have been described in some patients with NMOSD [15] [16] who were negative for the aquaporin 4 (AQP-4) antibody. However, most NMOSD is an astrocytopathy, specifically an AQP4 antibody-associated disease, whereas MOG antibody-associated disease is an oligodendrocytopathy, suggesting that these are two separate pathologic entities. [2]

  6. Chronic relapsing inflammatory optic neuropathy - Wikipedia

    en.wikipedia.org/wiki/Chronic_relapsing...

    Diagnosis requires exclusion of other neurological, ophthalmological, and systemic conditions. [3] Any cause of optic neuropathy should be ruled out, including demyelinating (MOG antibody disease, multiple sclerosis, and neuromyelitis optica) and systemic disease (diabetic, toxic, nutritional, and infectious causes). [3]

  7. Brenda Banwell - Wikipedia

    en.wikipedia.org/wiki/Brenda_Banwell

    In 2015, Banwell was on the International Panel for NMO Diagnosis (IPND) to develop international consensus diagnostic criteria for what became termed neuromyelitis optica spectrum disorder (NMO-SD). [23] She has also worked to determine the best treatment options for pediatric NMO-SD.

  8. Anti-neurofascin demyelinating diseases - Wikipedia

    en.wikipedia.org/wiki/Anti-neurofascin_demyelina...

    Neuromyelitis optica: NF auto antibodies can also appear in NMO cases. [2] These antibodies are more related to the peripheral nervous demyelination, but they were also found in NMO. [ 3 ] [ non-primary source needed ]

  9. Lesional demyelinations of the central nervous system

    en.wikipedia.org/wiki/Lesional_demyelinations_of...

    Devic's disease and neuromyelitis optica (NMO) (sometimes previously called optic-spinal MS) Acute disseminated encephalomyelitis or ADEM, a closely related disorder in which a known virus or vaccine triggers autoimmunity against myelin. Acute hemorrhagic leukoencephalitis, possibly a variant of Acute disseminated encephalomyelitis

  1. Ad

    related to: neuromyelitis optica spectrum disorder prognosis treatment